<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
<channel>
<title>Humana Inc — News on 6ix</title>
<link>https://6ix.com/company/humana-inc</link>
<description>Latest news and press releases for Humana Inc on 6ix.</description>
<language>en-us</language>
<lastBuildDate>Wed, 29 Apr 2026 10:00:00 GMT</lastBuildDate>
<generator>6ix RSS</generator>
<atom:link href="https://6ix.com/rss/company/humana-inc" rel="self" type="application/rss+xml" />
<image>
<url>https://6ix-events-pro.s3.amazonaws.com/6ixvideo/logos/org-logo6835803a78dffbe2df0fb5ae.webp</url>
<title>Humana Inc</title>
<link>https://6ix.com/company/humana-inc</link>
</image>
<item>
<title>Humana Reports First Quarter 2026 Financial Results; Affirms Full Year 2026 Adjusted Financial Guidance</title>
<link>https://6ix.com/company/humana-inc/news/humana-reports-first-quarter-2026-financial-results-affirms-full-year-2026-adjusted-financial-guidance</link>
<guid isPermaLink="true">https://6ix.com/company/humana-inc/news/humana-reports-first-quarter-2026-financial-results-affirms-full-year-2026-adjusted-financial-guidance</guid>
<pubDate>Wed, 29 Apr 2026 10:00:00 GMT</pubDate>
<description>LOUISVILLE, Ky., April 29, 2026--Humana Inc. (NYSE: HUM) today reported consolidated pretax results and diluted earnings per share (EPS) for the quarter ended March 31, 2026 (1Q26) versus the quarter ended March 31, 2025 (1Q25) as noted in the tables below.</description>
</item>
<item>
<title>CenterWell Pharmacy® and Mark Cuban Cost Plus Drug Company Teaming up to Develop Disruptive Medication Model</title>
<link>https://6ix.com/company/humana-inc/news/centerwell-pharmacyr-and-mark-cuban-cost-plus-drug-company-teaming-up-to-develop-disruptive-medication-model</link>
<guid isPermaLink="true">https://6ix.com/company/humana-inc/news/centerwell-pharmacyr-and-mark-cuban-cost-plus-drug-company-teaming-up-to-develop-disruptive-medication-model</guid>
<pubDate>Mon, 27 Apr 2026 12:00:00 GMT</pubDate>
<description>LOUISVILLE, Ky. & DALLAS, April 27, 2026--CenterWell Pharmacy®, a leader in specialty pharmacy and home delivery pharmacy and part of Humana Inc. (NYSE:HUM), today announced a deepened partnership with Mark Cuban Cost Plus Drug Company (Cost Plus Drugs) to develop new, end-to-end employer prescription solutions.</description>
</item>
<item>
<title>Tuesday Health Expands National Footprint With Humana Partnership to Advance Value-Based Palliative Care</title>
<link>https://6ix.com/company/humana-inc/news/tuesday-health-expands-national-footprint-with-humana-partnership-to-advance-value-based-palliative-care</link>
<guid isPermaLink="true">https://6ix.com/company/humana-inc/news/tuesday-health-expands-national-footprint-with-humana-partnership-to-advance-value-based-palliative-care</guid>
<pubDate>Tue, 14 Apr 2026 13:19:00 GMT</pubDate>
<description>Tuesday Health today announced a new partnership with Humana Inc. (NYSE: HUM) to expand access to value-based palliative care for Texans living with serious illness, marking another step in the company's growing national footprint. Launching June 1, the program will support eligible Humana members and their caregivers with coordinated clinical guidance, proactive symptom management and ongoing support designed to improve quality of life and help members receive care aligned with their individual</description>
</item>
<item>
<title>Humana Elects Robert S. Field to Board of Directors</title>
<link>https://6ix.com/company/humana-inc/news/humana-elects-robert-s-field-to-board-of-directors</link>
<guid isPermaLink="true">https://6ix.com/company/humana-inc/news/humana-elects-robert-s-field-to-board-of-directors</guid>
<pubDate>Fri, 10 Apr 2026 20:30:00 GMT</pubDate>
<description>LOUISVILLE, Ky., April 10, 2026--Humana Inc. (NYSE: HUM) announced today that Robert S. Field has been elected as a member of the Company’s Board of Directors, effective immediately following the Company’s 2026 Annual Meeting of Stockholders.</description>
</item>
<item>
<title>Humana Goes Live with b.well to Deliver on Health Data Interoperability Commitments</title>
<link>https://6ix.com/company/humana-inc/news/humana-goes-live-with-bwell-to-deliver-on-health-data-interoperability-commitments</link>
<guid isPermaLink="true">https://6ix.com/company/humana-inc/news/humana-goes-live-with-bwell-to-deliver-on-health-data-interoperability-commitments</guid>
<pubDate>Thu, 09 Apr 2026 10:00:00 GMT</pubDate>
<description>LOUISVILLE, Ky. & BALTIMORE, April 09, 2026--Humana goes live with b.well to deliver on health data interoperability goals.</description>
</item>
<item>
<title>Humana Healthy Horizons in Ohio and CPESN® USA Launch Value-Based Pharmacist Quality Rewards Program to Improve Chronic Condition Care</title>
<link>https://6ix.com/company/humana-inc/news/humana-healthy-horizons-in-ohio-and-cpesnr-usa-launch-value-based-pharmacist-quality-rewards-program-to-improve-chronic-condition-care</link>
<guid isPermaLink="true">https://6ix.com/company/humana-inc/news/humana-healthy-horizons-in-ohio-and-cpesnr-usa-launch-value-based-pharmacist-quality-rewards-program-to-improve-chronic-condition-care</guid>
<pubDate>Wed, 08 Apr 2026 12:30:00 GMT</pubDate>
<description>LOUISVILLE, Ky., April 08, 2026--Humana Healthy Horizons in Ohio and CPESN USA launch value-based Pharmacist Quality Rewards program to improve chronic condition care.</description>
</item>
<item>
<title>CORRECTING and REPLACING Humana Releases 2025 Impact Report, Highlighting Progress Towards Simpler, More Affordable Care for People and Communities</title>
<link>https://6ix.com/company/humana-inc/news/correcting-and-replacing-humana-releases-2025-impact-report-highlighting-progress-towards-simpler-more-affordable-care-for-people-and-communities</link>
<guid isPermaLink="true">https://6ix.com/company/humana-inc/news/correcting-and-replacing-humana-releases-2025-impact-report-highlighting-progress-towards-simpler-more-affordable-care-for-people-and-communities</guid>
<pubDate>Mon, 06 Apr 2026 18:37:00 GMT</pubDate>
<description>LOUISVILLE, Ky., April 06, 2026--Humana Releases 2025 Impact Report, Highlighting Progress towards Simpler, More Affordable Care for People and Communities</description>
</item>
<item>
<title>Humana Inc. to Release First Quarter 2026 Results on April 29, 2026</title>
<link>https://6ix.com/company/humana-inc/news/humana-inc-to-release-first-quarter-2026-results-on-april-29-2026</link>
<guid isPermaLink="true">https://6ix.com/company/humana-inc/news/humana-inc-to-release-first-quarter-2026-results-on-april-29-2026</guid>
<pubDate>Mon, 30 Mar 2026 20:30:00 GMT</pubDate>
<description>LOUISVILLE, Ky., March 30, 2026--Humana Inc. (NYSE: HUM) will release its financial results for the first quarter 2026 (1Q26), as well as prepared management remarks (in PDF format), at 6:00 a.m. Eastern time on April 29, 2026. The company will host a live question-and-answer session at 8:00 a.m. Eastern time that morning to discuss its financial results for the quarter and earnings guidance for 2026.</description>
</item>
<item>
<title>EO Care Appoints William Fleming and Kristi Savacool to Board of Directors, Reinforcing Its Leadership in Clinically Guided Cannabinoid Symptom Management</title>
<link>https://6ix.com/company/humana-inc/news/eo-care-appoints-william-fleming-and-kristi-savacool-to-board-of-directors-reinforcing-its-leadership-in-clinically-guided-cannabinoid-symptom-management</link>
<guid isPermaLink="true">https://6ix.com/company/humana-inc/news/eo-care-appoints-william-fleming-and-kristi-savacool-to-board-of-directors-reinforcing-its-leadership-in-clinically-guided-cannabinoid-symptom-management</guid>
<pubDate>Wed, 11 Mar 2026 12:05:00 GMT</pubDate>
<description>BOSTON, March 11, 2026--EO Care, Inc., a leading provider of clinically guided cannabinoid-based symptom management, today announced the appointment of William Fleming, PharmD, and Kristi Savacool to its Board of Directors. Both join as directors and investors, further strengthening the company’s governance, strategic depth, and national influence as cannabinoid care advances into mainstream healthcare delivery.</description>
</item>
<item>
<title>Humana Completes Aggregate $1.0 Billion Fixed-to-Fixed Rate Junior Subordinated Notes Offering</title>
<link>https://6ix.com/company/humana-inc/news/humana-completes-aggregate-dollar10-billion-fixed-to-fixed-rate-junior-subordinated-notes-offering</link>
<guid isPermaLink="true">https://6ix.com/company/humana-inc/news/humana-completes-aggregate-dollar10-billion-fixed-to-fixed-rate-junior-subordinated-notes-offering</guid>
<pubDate>Mon, 09 Mar 2026 21:00:00 GMT</pubDate>
<description>LOUISVILLE, Ky., March 09, 2026--Humana Inc. (the "company") (NYSE: HUM) announced today the completion of its public offering of $1.0 billion in aggregate principal amount of fixed-to-fixed rate junior subordinated notes due 2056, at 6.625 percent of the principal amount (the "Junior Subordinated Notes Offering").</description>
</item>
<item>
<title>AM Best Assigns Issue Credit Rating to Humana Inc.’s New Junior Subordinated Notes</title>
<link>https://6ix.com/company/humana-inc/news/am-best-assigns-issue-credit-rating-to-humana-incs-new-junior-subordinated-notes-31</link>
<guid isPermaLink="true">https://6ix.com/company/humana-inc/news/am-best-assigns-issue-credit-rating-to-humana-incs-new-junior-subordinated-notes-31</guid>
<pubDate>Fri, 06 Mar 2026 16:04:00 GMT</pubDate>
<description>OLDWICK, N.J., March 06, 2026--AM Best has assigned a Long-Term Issue Credit Rating of "bbb-" (Good) to the $1 billion, 6.625% fixed rate junior subordinated notes, due 2056, of Humana Inc. (Humana) (headquartered in Louisville, KY) [NYSE: HUM]. The outlook assigned to this Credit Rating (rating) is stable. All other ratings of Humana and its subsidiaries remain unchanged.</description>
</item>
<item>
<title>Humana Prices $1.0 Billion Fixed-to-Fixed Rate Junior Subordinated Notes Offering</title>
<link>https://6ix.com/company/humana-inc/news/humana-prices-dollar10-billion-fixed-to-fixed-rate-junior-subordinated-notes-offering-10</link>
<guid isPermaLink="true">https://6ix.com/company/humana-inc/news/humana-prices-dollar10-billion-fixed-to-fixed-rate-junior-subordinated-notes-offering-10</guid>
<pubDate>Fri, 06 Mar 2026 00:08:00 GMT</pubDate>
<description>LOUISVILLE, Ky., March 06, 2026--Humana Inc. (the "company") (NYSE: HUM) announced today that it has priced a public offering of $1.0 billion in aggregate principal amount of fixed-to-fixed rate junior subordinated notes due 2056, at 100.000 percent of the principal amount (the "Junior Subordinated Notes Offering"). The Junior Subordinated Notes Offering is expected to close on March 9, 2026, subject to the satisfaction of customary closing conditions.</description>
</item>
<item>
<title>Humana partners with Disabled American Veterans for the sixth year</title>
<link>https://6ix.com/company/humana-inc/news/humana-partners-with-disabled-american-veterans-for-the-sixth-year</link>
<guid isPermaLink="true">https://6ix.com/company/humana-inc/news/humana-partners-with-disabled-american-veterans-for-the-sixth-year</guid>
<pubDate>Wed, 04 Mar 2026 17:55:00 GMT</pubDate>
<description>ERLANGER, Ky., March 04, 2026 (GLOBE NEWSWIRE) -- DAV (Disabled American Veterans) has announced its continued partnership with Humana, one of the nation’s leading health and well-being companies. The relationship builds on Humana’s long-standing commitment to supporting veterans and expands its investment in organizations that provide critical programs and services for veterans and their families. Humana works to help people achieve their best health by partnering with communities, veterans ser</description>
</item>
<item>
<title>Humana Introduces New Value-Based Cardiology Care Partnerships for Medicare Advantage Members</title>
<link>https://6ix.com/company/humana-inc/news/humana-introduces-new-value-based-cardiology-care-partnerships-for-medicare-advantage-members</link>
<guid isPermaLink="true">https://6ix.com/company/humana-inc/news/humana-introduces-new-value-based-cardiology-care-partnerships-for-medicare-advantage-members</guid>
<pubDate>Tue, 03 Mar 2026 16:45:00 GMT</pubDate>
<description>LOUISVILLE, Ky., March 03, 2026--Humana introduces new value-based cardiology care partnerships for Medicare Advantage members.</description>
</item>
<item>
<title>Humana Foundation Increases Investment to Help End the Veteran Suicide Crisis</title>
<link>https://6ix.com/company/humana-inc/news/humana-foundation-increases-investment-to-help-end-the-veteran-suicide-crisis</link>
<guid isPermaLink="true">https://6ix.com/company/humana-inc/news/humana-foundation-increases-investment-to-help-end-the-veteran-suicide-crisis</guid>
<pubDate>Tue, 03 Mar 2026 14:00:00 GMT</pubDate>
<description>LOUISVILLE, Ky., March 03, 2026--The Humana Foundation, the philanthropic arm of Humana Inc. for the past 45 years, today announced an expanded commitment to Face the Fight®, a national, cross‑sector initiative dedicated to dramatically reducing veteran suicide. As a founding partner, the Foundation will invest $5 million to scale evidence informed solutions, strengthen data collection efforts, and expand support for community-based organizations serving veterans at high risk of suicide. This bu</description>
</item>
<item>
<title>Humana Inc. to Present at the 2026 Leerink Partners Global Healthcare Conference</title>
<link>https://6ix.com/company/humana-inc/news/humana-inc-to-present-at-the-2026-leerink-partners-global-healthcare-conference</link>
<guid isPermaLink="true">https://6ix.com/company/humana-inc/news/humana-inc-to-present-at-the-2026-leerink-partners-global-healthcare-conference</guid>
<pubDate>Thu, 26 Feb 2026 21:15:00 GMT</pubDate>
<description>LOUISVILLE, Ky., February 26, 2026--Humana Inc. (NYSE: HUM) announced today that Jim Rechtin, President and Chief Executive Officer, and Celeste Mellet, Chief Financial Officer, will make a presentation to investors at the Leerink Partners Global Healthcare Conference on Tuesday, March 10, 2026, at 10:40 a.m. Eastern time.</description>
</item>
<item>
<title>Humana Board Declares Payment of Quarterly Dividend to Stockholders</title>
<link>https://6ix.com/company/humana-inc/news/humana-board-declares-payment-of-quarterly-dividend-to-stockholders</link>
<guid isPermaLink="true">https://6ix.com/company/humana-inc/news/humana-board-declares-payment-of-quarterly-dividend-to-stockholders</guid>
<pubDate>Thu, 19 Feb 2026 11:30:00 GMT</pubDate>
<description>LOUISVILLE, Ky., February 19, 2026--Humana Inc. (NYSE: HUM) announced today that its Board of Directors has declared a cash dividend to stockholders of $0.885 per share payable on April 24, 2026 to stockholders of record as of the close of business on March 27, 2026.</description>
</item>
<item>
<title>Humana Invests $1.7 Million to Drive Better Health Outcomes Across Illinois</title>
<link>https://6ix.com/company/humana-inc/news/humana-invests-dollar17-million-to-drive-better-health-outcomes-across-illinois</link>
<guid isPermaLink="true">https://6ix.com/company/humana-inc/news/humana-invests-dollar17-million-to-drive-better-health-outcomes-across-illinois</guid>
<pubDate>Wed, 18 Feb 2026 13:45:00 GMT</pubDate>
<description>LOUISVILLE, Ky., February 18, 2026--Humana invests $1.7M to drive better health outcomes across Illinois.</description>
</item>
<item>
<title>CenterWell Completes Acquisition of MaxHealth from Arsenal Capital Partners</title>
<link>https://6ix.com/company/humana-inc/news/centerwell-completes-acquisition-of-maxhealth-from-arsenal-capital-partners</link>
<guid isPermaLink="true">https://6ix.com/company/humana-inc/news/centerwell-completes-acquisition-of-maxhealth-from-arsenal-capital-partners</guid>
<pubDate>Fri, 13 Feb 2026 21:15:00 GMT</pubDate>
<description>CenterWell, the healthcare services division of Humana Inc., today announced the successful completion of its acquisition of MaxHealth from Arsenal Capital Partners ("Arsenal"), a private equity investment firm that specializes in building market-leading industrial growth and healthcare companies, and MaxHealth's founder-shareholders. MaxHealth currently maintains a network of 54 owned primary care clinics, 4 owned specialty/ancillary clinics and 24 downstream affiliate clinics throughout West a</description>
</item>
<item>
<title>Humana Reports Fourth Quarter 2025 Financial Results; Provides Full Year 2026 Financial Guidance</title>
<link>https://6ix.com/company/humana-inc/news/humana-reports-fourth-quarter-2025-financial-results-provides-full-year-2026-financial-guidance</link>
<guid isPermaLink="true">https://6ix.com/company/humana-inc/news/humana-reports-fourth-quarter-2025-financial-results-provides-full-year-2026-financial-guidance</guid>
<pubDate>Wed, 11 Feb 2026 11:00:00 GMT</pubDate>
<description>LOUISVILLE, Ky., February 11, 2026--Humana Inc. (NYSE: HUM) today reported consolidated pretax results and net (loss) earnings per share (EPS) for the quarter ended December 31, 2025 (4Q25) versus the quarter ended December 31 31, 2024 (4Q24) and for the year ended December 31, 2025 (FY 2025) versus the year ended December 31, 2024 (FY 2024) as noted in the tables below.</description>
</item>
</channel>
</rss>